Resources from the same session
Introduction and scientific background
Presenter: Erica Mayer
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
Critical organ damage and late toxicities from anti-PD1
Presenter: Jarushka Naidoo
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
Chronic toxicities of targeted therapies and their implication on compliance: Illustration with new endocrine therapies and CDK4 inhibitors
Presenter: Erica Mayer
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
Toxicities of CAR T cell and bispecific
Presenter: Claire Roddie
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
Discussion: How to design better trial taking into account toxicities
Presenter: All Speakers
Session: Emerging toxicities of new anticancer therapies
Resources:
Webcast